Antimicrobial surface coating material

    公开(公告)号:US11154056B2

    公开(公告)日:2021-10-26

    申请号:US15771391

    申请日:2016-10-21

    Abstract: The present invention relates to surfaces which are featured with antimicrobial property. Combinations made with zinc pyrithione, chlorhexidine gluconate and/or triclosan are used in the invention. The invention enables to prevent biodegradation or biocontamination occurring on surfaces. In sectors where surface coating materials are widely used, the pathogen factors (bacteria, yeasts and fungi), which are the causes of surface-borne hygiene, allergy and infectious diseases, are controlled.

    Application of stem cells in the orthodontic maxillary expansion

    公开(公告)号:US09827269B2

    公开(公告)日:2017-11-28

    申请号:US14433677

    申请日:2013-10-04

    CPC classification number: A61K35/28 A61C7/10

    Abstract: This invention relates to the contributions of the bone marrow—and adipose tissue—derived mesenchymal stem cells applied following the maxillary expansion—a frequently used method for the orthodontic treatment—to the healing of the expanded bone tissues. In the invention, adipose tissue and bone marrow-derived stem cell applications increased the healing and quality of the bones following the maxillary expansion and the applied stem cells were involved in the bone structure. Thus, the relapse following the maxillary expansion treatment was avoided. This application will shorten the treatment period for patients undergoing the maxillary expansion treatment and the patients will not have to use apparatus for a long period of time.

    Cape-loaded targeted microvesicular cancer drug and method for developing the same

    公开(公告)号:US12138235B2

    公开(公告)日:2024-11-12

    申请号:US17840700

    申请日:2022-06-15

    Abstract: A method of producing a caffeic acid phenethyl ester loaded microvesicular cancer drug targeting SH-SY5Y neuroblastoma cancer. The method includes seeding a plurality of skin stem cells in a medium; enabling the plurality of skin stem cells in the medium to reach a confluency of 70-80% to be seeded in a plurality of culture plates; preparing a caffeic acid phenethyl ester stock solution by dissolving the caffeic acid phenethyl ester in dimethyl sulfoxide DMSO; performing a microvesicle isolation from specialized skin cells; adding the caffeic acid phenethyl ester into a plurality of microvesicles; and separating the caffeic acid phenethyl ester loaded microvesicles from the caffeic acid phenethyl ester which is free in the solution and not loaded to a microvesicle.

    APPLICATION OF STEM CELLS IN THE ORTHODONTIC MAXILLARY EXPANSION
    19.
    发明申请
    APPLICATION OF STEM CELLS IN THE ORTHODONTIC MAXILLARY EXPANSION 有权
    干细胞在正常超最大扩张中的应用

    公开(公告)号:US20150231179A1

    公开(公告)日:2015-08-20

    申请号:US14433677

    申请日:2013-10-04

    CPC classification number: A61K35/28 A61C7/10

    Abstract: This invention relates to the contributions of the bone marrow—and adipose tissue—derived mesenchymal stem cells applied following the maxillary expansion—a frequently used method for the orthodontic treatment—to the healing of the expanded bone tissues. In the invention, adipose tissue and bone marrow-derived stem cell applications increased the healing and quality of the bones following the maxillary expansion and the applied stem cells were involved in the bone structure. Thus, the relapse following the maxillary expansion treatment was avoided. This application will shorten the treatment period for patients undergoing the maxillary expansion treatment and the patients will not have to use apparatus for a long period of time.

    Abstract translation: 本发明涉及在上颌扩张后施用的骨髓和脂肪组织的间充质干细胞(经常使用的正畸治疗方法)对扩张的骨组织的愈合的贡献。 在本发明中,脂肪组织和骨髓来源的干细胞应用增加了上颌扩张后骨骼的愈合和质量,并且所应用的干细胞参与骨结构。 因此,避免了上颌扩张治疗后的复发。 该应用将缩短上颌扩张治疗患者的治疗期,患者长时间不用使用器械。

Patent Agency Ranking